Post-ERCP Pancreatitis Prevention by Stent Insertion

Technical University of Munich169 enrolled

Overview

The presented study is designed to analyze the efficacy of pancreatic stent insertion in patients undergoing ERCP with accidental cannulation of the pancreatic duct.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

169

Conditions

Post-ERCP Acute Pancreatitis

Interventions

Stent insertion into the main pancreatic ductDEVICE

Stent insertion into the main pancreatic duct

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all patients undergoing ERCP with unintended cannulation or opifiacation of main pancreatic duct * age \> 17 years * signed informed consent Exclusion Criteria: * intention to intervene main pancreatic duct * age \< 18 years * pregnancy * absent of signed informed consent

Locations (4)

Deptartment of Hepatobiliary Diseases Leuven University Hospitals

Leuven, Belgium

Klinikum rechts der Isar, Technische Universität München

Munich, Germany

P. Stradin Clinical University Hospital Gastroenterology Centere Latvijas Universitates Medicinas

Riga, Latvia

First city hospital of emergency care Northern State Medical University

Arkhangelsk, Russia

Outcomes

Primary Outcomes

Incidence of post-ERCP pancreatitis

Time frame: up to 1 week

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.